The diagnosis of vasculitis

被引:55
作者
Jayne, David [1 ]
机构
[1] Addenbrookes Hosp, Renal Unit, Cambridge CB2 2QQ, England
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2009年 / 23卷 / 03期
关键词
vasculitis; diagnosis; anti-neutrophilic cytoplasmic antibodies; histology; classification; infection; malignancy; RHEUMATOLOGY; 1990; CRITERIA; WEGENERS-GRANULOMATOSIS; SYSTEMIC VASCULITIS; CLASSIFICATION; THERAPY; POLYARTERITIS; ANTIBODIES;
D O I
10.1016/j.berh.2009.03.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Early diagnosis of primary systemic vasculitis is important to allow the early commencement of therapy in order to avoid damage and poor outcomes. The heterogeneous nature of vasculitis presents a diagnostic challenge which may hinder early diagnosis. Anti-neutrophilic cytoplasmic antibody testing has been of particular benefit in defining a Subgroup of small-vessel vasculitides and facilitating their earlier diagnosis. Suspicion of vasculitis is an important first step to begin a process of investigation to make or refute the diagnosis. No useful diagnostic criteria exist, but classification criteria have been developed to permit a vasculitis patient to be placed in a diagnostic subgroup. The exclusion of vasculitis 'mimics' and secondary causes of vasculitis are components of diagnosis, which otherwise relies on the recognition of a compatible clinical presentation supported by specific laboratory or imaging tests and confirmatory histology. When the diagnosis remains Uncertain, observation over time, repeat investigation and a therapeutic trial may improve the probability of the diagnosis or identify an alternative disease. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:445 / 453
页数:9
相关论文
共 24 条
[1]  
ANDREWS M, 1990, J ROY COLL PHYS LOND, V24, P284
[2]   Primary central nervous system vasculitis: Progress and questions [J].
Calabrese, Leonard H. ;
Molloy, Eamonn S. ;
Singhal, Aneesh B. .
ANNALS OF NEUROLOGY, 2007, 62 (05) :430-432
[3]  
Choi HK, 2001, J RHEUMATOL, V28, P1584
[4]   The use and abuse of commercial kits used to detect autoantibodies [J].
Fritzler, MJ ;
Wiik, A ;
Fritzler, ML ;
Barr, SG .
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (04) :192-201
[5]   Giant cell arteritis in northwestern Spain - A 25-year epidemiologic study [J].
Gonzalez-Gay, Miguel A. ;
Miranda-Filloy, Jose A. ;
Lopez-Diaz, Maria J. ;
Perez-Alvarez, Roberto ;
Gonzalez-Juanatey, Carlos ;
Sanchez-Andrade, Amalia ;
Martin, Javier ;
Llorca, Javier .
MEDICINE, 2007, 86 (02) :61-68
[6]   Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis [J].
Hagen, EC ;
Daha, MR ;
Hermans, J ;
Andrassy, K ;
Csernok, E ;
Gaskin, G ;
Lesavre, P ;
Lüdemann, J ;
Rasmussen, N ;
Sinico, RA ;
Wiik, A ;
van der Woude, FJ .
KIDNEY INTERNATIONAL, 1998, 53 (03) :743-753
[7]  
Henes JC, 2008, CLIN EXP RHEUMATOL, V26, pS47
[8]  
HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1065
[9]   Current attitudes to the therapy of vasculitis [J].
Jayne, D .
KIDNEY & BLOOD PRESSURE RESEARCH, 2003, 26 (04) :231-239
[10]   A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies [J].
Jayne, D ;
Rasmussen, N ;
Andrassy, K ;
Bacon, P ;
Tervaert, JWC ;
Dadoniene, J ;
Ekstrand, A ;
Gaskin, G ;
Gregorini, G ;
de Groot, K ;
Gross, W ;
Hagen, EC ;
Mirapeix, E ;
Pettersson, E ;
Siegert, C ;
Sinico, A ;
Tesar, V ;
Westman, K ;
Pusey, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (01) :36-44